Prevalence of Cryptococcal Antigenemia and associated factors among HIV/AIDS patients on second-line antiretroviral therapy at two hospitals in Western Oromia, Ethiopia

被引:8
|
作者
Geda, Nuguse [1 ]
Beyene, Tafese [2 ]
Dabsu, Regea [1 ]
Mengist, Hylemariam Mihiretie [3 ]
机构
[1] Wollega Univ, Inst Hlth Sci, Dept Med Lab Sci, Nekemte, Ethiopia
[2] Arsi Univ, Coll Hlth Sci, Dept Med Lab Sci, Assela, Ethiopia
[3] Debre Markos Univ, Coll Hlth Sci, Dept Med Lab Sci, Debre Markos, Ethiopia
来源
PLOS ONE | 2019年 / 14卷 / 12期
关键词
D O I
10.1371/journal.pone.0225691
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Cryptococcosis is a global public health important infectious disease. HIV infection is the main risk factor estimated to account for 95% of cases in the middle- and low-income countries and 80% of the cases in high-income countries. Objective The main aim of the study was to determine the prevalence and associated risk factors of Cryptococcal antigenemia (CrAg) among HIV/AIDS Patients on second-line ART Therapy at Ambo General Hospital and Nekemte Referral Hospital, Western Oromia, Ethiopia. Materials and methods Hospital-based cross-sectional study was employed from September 1, 2017, to October 30, 2017. Whole blood was tested for CrAg using Cryptococcal lateral flow assay (Immuno-Mycologics, Norman, OK, USA) according to the manufacturer's instructions. The collected data were analyzed using SPSS version 20 software. Binary logistic regression models were applied to assess the association between predictors and outcome variables at 95% CI. Result Among the study participants, 115(62.8%) were females and the median age of the participants was 35 (IQR: 14) years. Majority, 169(92.3%), have been living with HIV for >= 5.6 years and 124 (67.8%) stayed on 2nd line ART for an average of 2.5 years. The overall prevalence of Cryptococcal antigenemia in the study participants was 7.7% (14/183). Being male [AOR, 95% CI: 4.78(1.14, 20.1)], poor adherence to ART [AOR, 95% CI: 0.12(0.03, 0.4)], occupational exposures to contaminated soil [AOR, 95% CI: 6.81(1.38, 33.4)], having non-separated house from chickens [AOR, 95% CI: 0.06(0.01, 0.51)], CD4 T+ cell levels <= 100 cell/mu L [AOR, 95% CI: 6.57(1.9, 23.3)] and viral load > 1000 copies/mL [AOR, 95% CI: 11.7(2.4, 57.8)] were significant predictors of Cryptococcal antigenemia (P <= 0.05). Conclusion The prevalence of Cryptococcal Antigenemia was significantly high in this study. Being male, occupational exposure to contaminated soil with avian droppings, CD4+ T cell levels < 100 cell/mu L and viral load > 1000 copies/mL were significant predictors of Cryptococcal antigenemia. Therefore, public health measures, adherence to ART and early treatment are recommended.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Prevalence of cryptococcal antigenemia and associated factors among HIV/AIDS patients on second-line antiretroviral therapy at two hospitals in Western Oromia, Ethiopia
    Geda, N.
    Dabsu, R.
    Beyene, T.
    Mengist, H. M.
    CLINICA CHIMICA ACTA, 2019, 493 : S558 - S559
  • [2] High Prevalence of Cryptococcal Antigenemia among HIV-infected Patients Receiving Antiretroviral Therapy in Ethiopia
    Alemu, Abere Shiferaw
    Kempker, Russell R.
    Tenna, Admasu
    Smitson, Christopher
    Berhe, Nega
    Fekade, Daniel
    Blumberg, Henry M.
    Aseffa, Abraham
    PLOS ONE, 2013, 8 (03):
  • [3] Comparison of Cryptococcal Antigenemia between Antiretroviral Naive and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia
    Beyene, Tafese
    Woldeamanuel, Yimtubezinash
    Asrat, Daniel
    Ayana, Gonfa
    Boulware, David R.
    PLOS ONE, 2013, 8 (10):
  • [4] Prevalence of Cryptococcal Antigenemia and Associated Factors among HIV/AIDS Patients at Felege-Hiwot Referral Hospital, Bahir Dar, Northwest Ethiopia
    Jemal, Mohabaw
    Deress, Teshiwal
    Belachew, Teshome
    Adem, Yesuf
    INTERNATIONAL JOURNAL OF MICROBIOLOGY, 2021, 2021
  • [5] Risky Sexual Practice and Associated Factors Among Women Living with HIV/AIDS Receiving Antiretroviral Therapy at a PMTCT Clinic in Western Oromia, Ethiopia
    Balis, Bikila
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2020, 12 : 739 - 747
  • [6] Incidence and factors associated with treatment failure among HIV infected adolescent and adult patients on second-line antiretroviral therapy in public hospitals of Northern Ethiopia: Multicenter retrospective study
    Haftu, Adisu Zenebe
    Desta, Abraham Aregay
    Bezabih, Nega Mamo
    Kahsay, Alemayehu Bayray
    Kidane, Kibriti Mehari
    Zewdie, Yodit
    Woldearegay, Tewolde Wubayehu
    PLOS ONE, 2020, 15 (09):
  • [7] Factors associated with adherence and viral suppression among patients on second-line antiretroviral therapy in an urban HIV program in Kenya
    Nyaboke, Rose
    Ramadhani, Habib Omari
    Lascko, Taylor
    Awuor, Patrick
    Kirui, Elvis
    Koech, Emily
    Mutisya, Immaculate
    Ngunu, Carol
    Wangusi, Rebecca
    SAGE OPEN MEDICINE, 2023, 11
  • [8] Effectors of Hyperlipidemia Among Patients with HIV/AIDS Taking Second-line Antiretroviral Therapy Based on Registry Data
    Yang, Chunling
    Wang, Dongli
    Ma, Yanmin
    Liu, Zhibin
    Guo, Huijun
    Sang, Feng
    Xu, Qianlei
    Jin, Yantao
    CURRENT HIV RESEARCH, 2022, 20 (05) : 373 - 379
  • [9] Viral Suppression and HIV Drug Resistance Among Patients on Second-Line Antiretroviral Therapy in Selected Health Facility in Ethiopia
    Zealiyas, Kidist
    Gebreegziabxier, Atsbeha
    Getaneh, Yimam
    Kidane, Eleni
    Woldesemayat, Belete
    Yizengaw, Ajanaw
    Gutema, Gadisa
    Adane, Sisay
    Yimer, Mengistu
    Yilma, Amelework
    Tadele, Sisay
    Sasinovich, Sviataslau
    Medstrand, Patrik
    Arimide, Dawit Assefa
    VIRUSES-BASEL, 2025, 17 (02):
  • [10] The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa
    Long, Lawrence
    Fox, Matthew
    Sanne, Ian
    Rosen, Sydney
    AIDS, 2010, 24 (06) : 915 - 919